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The inclusion complex of HF with β-CD has been prepared by 
various synthetic method such as physical method (PM), kneading 
method (KM) and co-precipitation method (CP) and characterized 
by UV, luminescence spectra, Fourier transform infrared 
spectroscopy, scanning electron microscopy and powder X-ray 
diffraction. Investigations into the anticancer activity of the solid 
complex against breast cancer cell line show that it is not much 
better than that of the HF alone. Both the HF and its solid complex 
show the poor anticancer activity against MDA MB 231 cell line. 
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3-Hydroxyflavone is the backbone of all flavonols, 
and is a model molecule as it possesses an excited-
state intramolecular proton transfer (ESIPT) effect1 
to serve as a fluorescent probe to study membranes2 
and intermembrane proteins3. Although 3-hydroxy-
flavone is almost insoluble in water, its aqueous 
solubility (hence bio-availability) can be increased 
by encapsulation in cyclodextrin cavities4. 
Cyclodextrins (CD) are cyclic oligosaccharides 
formed from D-glucose units that provide a 
relatively hydrophobic binding site for guest 
molecules. The most common CDs have six α,  
seven β, or eight γ glucose units for which  
the internal cavity diameter varies between 5 and  
8 Å (refs 5, 6). The CDs have been widely employed 
as host molecules in supramolecular chemistry since 
the size of their cavities can be systematically varied 
and the hydroxyl groups at both rims can be 
derivatized7.  In addition, CD are chiral, and this 
property has been explored for separation 
technology7 and the complexation of various guests. 
Guest molecules can interact with different regions 
of the CD, and different inclusion modes have been 
observed, e.g., inclusion within the cavity or binding 
to the rim. The inclusion complexation of guest 
molecules by the host cyclodextrins and chemically 
modified cyclodextrins has been extensively studied 
in recent years as models of biological receptor-
substrate interactions and is currently a significant 
topic in chemistry and biochemistry8-11.  
β-Cyclodextrin is widely used because it is readily 
available and its cavity size is suitable for many 
guest molecules12. The core structure of  
β-cyclodextrin is well known with the hydrophilic 
outer surface and a hydrophobic inner cavity13. β-CD 
with inclusion complex properties has been widely 
used in different areas, such as the medicine14-17, 
chemistry18-19, agriculture20-21, etc. 
We have earlier reported complexation of some 
organic compounds with β-CD based on proton shift 
effect22-24. Herein, we have evaluated the effect of 
inclusion complexation of HF with β-cyclodextrin in 
the solid state. The inclusion complex has been 
characterized by UV, fluorescence spectra, FT-IR and 
Powder X-ray diffraction patterns. Herein, we have 
also investigated the anticancer effect of pure HF and 
its solid complexes against MDA MB 231 cell line. 
 
Experimental 
Hydroxyflavone (HF) and β-cyclodextrin (β-CD) 
were purchased from Alfa Acer and used as  
received. Distilled water was used throughout the 
study. 3-(4,5-Dimethyl thiazol-2-yl)-5-diphenyl 
tetrazolium bromide (MTT), fetal bovine serum 
(FBS), Phosphate buffered saline (PBS), Dulbecco’s 
modified eagle’s medium (DMEM) and trypsin were 
obtained from Sigma Aldrich Co, St Louis, USA. 
EDTA, glucose and antibiotics were procured  
from Hi-Media Laboratories Ltd., Mumbai, while 
dimethyl sulfoxide (DMSO) and propanol were from 
E. Merck Ltd., Mumbai, India. 




MDA MB 231 (Breast carcinoma) cell line was 
procured from National Centre for Cell Sciences 
(NCCS), Pune, India. Stock cells were cultured in 
DMEM supplemented with 10% inactivated fetal 
bovine serum (FBS), penicillin (100 IU/mL), 
streptomycin (100 µg/mL) and amphotericin B  
(5 µg/mL) in a humidified atmosphere of 5% CO2 at 
37 ◦C until confluent. The cells were dissociated with 
TPVG solution (0.2% trypsin, 0.02% EDTA, 0.05% 
glucose in PBS). The stock cultures were grown in 25 
cc culture flasks and all experiments were carried out 
in 96 microtitre plates (Tarsons India Pvt. Ltd., 
Kolkata, India). 
The solid inclusion complexes of HF and β-CD 
were prepared in the molar ratio of 1:1 using  
the physical mixture, kneading method and  
co-precipitation techniques. In the physical mixture 
process, accurately weighed HF and β-CD (molar 
ratio: 1:1) were kept under continuous agitation using 
a mortar and pestle for 10 min. The homogeneous 
mixture of HF and β-CD thus obtained was 
designated as physical mixture (PM) 
In the kneading method, the pure HF and β-CD 
were accurately weighed at a molar ratio of 1:1 and 
transferred to a pestle and mortar. Then, sufficient 
quantity of water was added to make a pasty form, 
which was ground further up to half an hour with 
pestle and mortar. The yellow powder obtained after 
drying for 48 h in an oven at 303 K was designated as 
kneading products. 
In the coprecipitation method, the inclusion 
complex of HF and β-CD at 1:1 molar ratio was 
prepared by dissolving accurately weighed amount 
(0.75 g) of β-CD in distilled water to obtain a 
saturated solution. Separately, accurately weighed 
amount of (0.75 g) HF was dissolved in distilled 
water to get a saturated solution. The HF solution was 
added slowly to the β-CD solution till a suspension 
was formed. The suspension was stirred continuously 
for 48 h at 303 K and kept in a refrigerator for 24 h. 
After 24 h, a yellow precipitate was obtained which 
was designated as solid complex of HF with β-CD. 
For cytotoxicity studies, weighed test drugs were 
separately dissolved in distilled DMSO and volume 
was made up with DMEM supplemented with 2% 
inactivated FBS to obtain a stock solution of 1 mg/mL 
concentration. Serial two-fold dilutions were prepared 
from these stock solutions for cytotoxic studies. 
UV-visible spectra are recorded with UV-1800 
Shimadzu spectrophotometer, while fluorescence 
spectra were recorded in the wavelength range of 
270800 nm with RF-5301PC spectrofluorophotometer. 
FT-IR spectra were obtained with iD1 Thermo 
nicolate iS5 FT-IR spectrophotometer using KBr 
pellet, in the range of 500-4000 cm-1. Microscopic 
morphological structures were recorded with FEI 
Quanta FEG 200 scanning electron microscope. 
Powder X-ray diffraction spectra were recorded on 
D8 Advance X-ray instrument (Bruker, Germany) 
with 2.2 KW Cu anode and ceramic X-ray tube as the 
source, Lynx Eye (Silicon strip detector technology) 
as the detector, Ni filter as the beta filter and zero 
back ground sample holder ( PMMA sample holder). 
TG/DTA analysis was carried out with TGA 4000 
Perkin Elmer in nitrogen atmosphere at 20mL/min, in 
the temperature range of 35-600 ◦C at a heating rate 
of 10 °C/min. 
 
Results and discussion 
UV-visible spectra of pure HF, PM, KM and solid 
complex (CP) are given in Fig. 1. The pure HF shows 
the maximum at 440.0 nm, while for PM and KM 
products the maxima are seen at 443.0 and 444.0 nm, 
respectively. The absorption maximum for the solid 
complex is seen at at 450.0 nm. Here we observed a 
change in absorption maximum for PM and KM, as 
compared with that of pure HF. This small change is 
due to the presence of β-CD. On the other hand, red 
shifted maximum is observed (10 nm) with 
significance enhancement in absorbance for solid 
complex in comparison with that of pure HF, PM and 
KM. This change is attributed to the formation of 
inclusion complex between HF and β-CD. 
Figure 2 depicts the fluorescence spectra of pure 
HF, PM, KM and solid complex (CP). HF shows 
emission maximum at 560.0 nm with fluorescence 
intensity  of  40.0,  while  the  emission   maxima   are  
 
 
Fig. 1 – UV-vis spectra of pure HF (1), physical mixture (2), 





observed at 561.0 and 563.0 nm with the intensity of 
125 and 145.0 for PM and KM products, respectively. 
The λemission at 567.0 nm is observed with intensity of 
220.0 for the solid complex. Not much change is 
observed in the emission maximum and its intensity 
for the PM and KM products which closely resembles 
the fluorescence spectra of pure HF. This small 
change in maximum and its respective intensity is only 
due to the presence of β-CD role in it. On the other hand, 
red shift is observed (around 7.0 nm) with significant 
enhancement in intensity for the solid complex  
(CP product) as compared to pure HF, PM and KM. 
This significant change is attributed to the formation of 
the inclusion complex between HF and β-CD. 
The formation of inclusion complex was further 
confirmed by FT-IR spectral study by comparison of 
the guest molecule with the solid complex. IR spectra 
of the physical mixture, KM, and CP products are 
represented in Fig. 3. The FT-IR band of β-CD is 
observed at 3385.23 cm-1 due to symmetric stretching 
of ν(OH). Also, in the IR spectrum of β-CD, the 
absorption band with maximum at 2924.70 cm-1 is 
observed, which is attributed to the valence vibration 
of the C-H bonds in the CH and CH2 groups. 
Absorption peaks are observed at 1157.30 cm-1, 
1079.98 cm-1 and 1028 cm-1 which correspond to the 
symmetrical ν(C-C), ν(C-O-C) and bending vibration 
of ν(OH), respectively. The absorption bands in the 
region 950-700 cm-1 belong to the deformation 
vibration of the C-H bonds and the pulsation vibration 
in glucopyranose cycle. 
Among all the possible stretching frequencies of 
HF, we have selected some important stretching 
frequencies for discussion. In the IR spectrum of HF a 
strong absorption peak is seen at 1608.51 cm-1 for 
aromatic C=C.  The stretching frequencies for HF 
observed at 3178, 3469.64 and 1280 cm-1 which 
corresponds to the presence of aromatic C-H, -OH 
and C-O-C, respectively. 
The IR spectrum of the solid complex of HF with 
β-CD (Fig. 3) differs from the IR spectra of free β-CD 
and HF. The band of the OH functional group of  
HF and β-CD is shifted to lower wave number at  
3540 cm-1. At the same time, the vibration band and 
ν(C-O-C) is shifted to higher wave number at  
1289.72 cm-1 with 22% transmittance. The decrease in 
the ν(OH) between the inclusion complex of HF and 
β-CD, and HF is due to the changes in the 
microenvironment which leads to the formation of 
hydrogen bonding and the presence of the van der 
Walls forces during their interaction to form the 
inclusion complex. On the other hand, the FT-IR 
spectra of PM and KM products almost imitates the 
characteristic peaks of free β-CD and HF, which can 
be regarded as a simple superimposition of free β-CD 
and HF molecules. Thus, the FT-IR spectrum 




Fig. 2 – Fluorescence spectra of pure HF(1), physical mixture (2), 




Fig. 3 – FT-IR spectra of pure HF (1), β-CD (2), physical mixture 
(3), kneading mixture (4), and, inclusion complex of HF: β-CD (5). 
 




Scanning electron microscopy (SEM) has been 
employed to investigate the microstructures of the 
inclusion complexes in the solid state. Figure 4(a-d) 
shows the SEM images of HF, β-CD, PM, KM 
products and solid complex at X500 magnification, 
while Fig. 4(a'-d') shows the same at 2000X 
magnification to visualize the size and shape of each 
category. Clear rock and the needle structure are seen 
for pure HF for both magnifications. The complexed 
form of HF also shows the needle image, but it has 
quite different from that of HF alone. The PM and 
KM products are prepared by simple mixing of HF 
with β-CD. Hence, the images appear as such without 
any differences (Fig. 4b and 4c). Further, SEM 
images also show that the shape and size of the 
inclusion complex are completely different from those 
of free HF and β-CD. A comparison of SEM images 
shows the complex formation between HF and β-CD 
in the solid state. 
Generally the crystalline nature of the guest 
molecule is reduced and the number of amorphous 
structures is increased in the solid inclusion 
complex25. Hence, the solid complexes usually reveal 
a smaller number and less intense peaks. Figure 5 
shows the XRD patterns of pure HF, β-CD, inclusion 
complexes prepared by CP method, as well as PM and 
KM products. The characteristic diffraction peaks of  
HF are observed at 2θ 11.59°, 16.15°, 18.24°, 25.87° 
and 32.86° (Fig. 5, curve 1). Some sharp peaks at 2θ 
10.75°, 12.67°, 15.43°, 19.62° and 22.82° are present 
in the β-CD powder (Fig. 5, curve 2). The diffraction 
patterns of solid complex of HF show peaks at 10.62°, 
15.17°, 17.94°, 24.38° and 30.75° (Fig. 5, curve 5). 
The intensity peaks at 2θ 11.59°, 16.15°, 18.24°, 
25.87° and 32.86° of HF are reduced significantly in 
diffraction patterns of HF:β-CD inclusion complex, 
which suggests the reduction in the crystalline nature 
of HF on addition of β-CD. The crystalline nature of 
HF is lost during the formation of the stable complex 
with β-CD. Moreover, the change in diffraction 
patterns of solid complex  is  only  due to the 
inclusion of HF molecule into the cavity of β-CD. 
Further, new intense diffraction peaks are also observed 
 
 
Fig. 4 – SEM photographs of the compounds at 500X 
magnification. (a) pure HF, (b) physical method,  (c) kneading 
method and (d) HF:β-CD inclusion complex. [(a'-d') are the 
corresponding images at 2000X magnification]. 
 
 
Fig. 5 – Powder XRD patterns of pure HF (1), β-CD (2), physical 






for HF-β-CD inclusion complex, which indicates a 
change in HF-β-CD environment after inclusion 
complex formation. 
The pattern of the PM product is similar to that of 
β-CD, while the pattern of KM product (Fig. 5, curves 
3 and 4) is similar to that of pure HF. Not much 
difference is noted for PM and KM products of HF by 
the addition of β-CD. Only a slight decrease in peak 
intensity is noted. Hence, No inclusion complex is 
obtained in the case of PM and KM. 
The TG/DTA curves obtained for the pure HF, PM, 
KM and CP products are presented in Fig. 6. The 
TG/DTA curve of β-CD shows three endothermic 
peaks. The first endothermic peak between 69.5 °C 
and 118 °C with 12% weight loss corresponds to the 
dehydration of β-CDx. There were nine water 
molecules per β-CD molecule. The second small 
endothermic peak appears at 225 °C, while no weight 
loss is seen in the TG curve, indicating a  reversible 
trans conformation26. TG/DTA curve of pure HF 
exhibits an endothermic peak at 268.89 °C assigned  
to the melting point of the pure HF molecule.  
For  physical  mixture  (Fig. 6b)  this  peak  is seen at 
263.12 °C and for the KM product, the endothermic 
peak is at 251.34 °C. The minor change observed for 
PM and KM is due to the small interaction between 
HF and β-CD. On the other hand, the endothermic 
peak at 262.65 °C for the solid complex (Fig. 6d) is 
due to the strong influence of β-CD on the HF 
molecule. From the thermal analysis, the formation of 
solid complex is confirmed. 
In vitro comparison of cytotoxicity of free HF,  
β-CD and inclusion complex was assessed to verify its 
safe application in pharmaceutical formulations. The 
cytotoxic effects of pure HF and its solid complex with 
β-CD were tested with MDA MB 231 cell line, at 
varying concentrations of pure HF and its solid 
complex in the order of 62.5, 125, 250, 500 and  
1000 µm/mL individually. The percentage of inhibition 
and corresponding CTC50 value for each concentration 
is given in Table 1. On increasing the concentration of 
HF, the percentage of inhibition is gradually increased. 
At higher concentration of HF (1000 mg/mL) it is 
22.22% with the CTC50 value exceeding 1000. The 
 
 
Fig. 6 – TG/DTA of (a) pure HF, (b) physical mixture, (c) kneading method, and, (d) inclusion complex of HF: β-CD. 
 




solid complex of HF with β-CD showed the same  
trend with percentage of inhibition of 19.33% and 
CTC50 value exceeding 1000. Both the compounds 
showed only a minor effect against MDA MB 231 cell 
line (≈20% inhibition). When the CTC50 value is  
less than 1000, it is considered safe for cytotoxic 
activity. However, in this case we observed CTC50 
value exceeding 1000. Hence, the cytotoxic effect  
of pure HF and its complex did not reach the  
expected level. 
Figure 7 shows that there is no major difference 
between the cytotoxic activities of pure HF and solid 
complex. β-CD inclusion does not induce or increase 
toxicity of HF. Hence, cyclodextrin based approach 
for design of new formulations of HF would be an 
interesting strategy and may have potential 
application in the design and development of β-CD 
associated pharmaceutical formulations. 
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Table 1 – Cytotoxic activity of HF and its inclusion complex 
against MDA MB 231 cell line 
 
No. Comp.  Conc 
(µg/mL) 
%Inhibition  CTC50 
(µg/mL) 
 




























Fig. 7 – Cytotoxic activity of pure HF (1), and, solid inclusion 
complex (2) against MDA MB 231 cell line. 
 
